Disclosures for "A Novel Combination of Blood Diagnostic Biomarkers Identify Neuro Post-Acute Sequalae of COVID-19 with 90% Accuracy "
-
Dr. Tachas has stock in Percheron Therapeutic. Dr. Tachas has received personal compensation in the range of $100,000-$499,999 for serving as a Principal Scientist with Percheron Therapeutics Ltd.
-
Dr. Hanson has nothing to disclose.
-
The institution of Dr. Visvabharathy has received research support from NIH.
-
Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
-
Mr. Padhye has received personal compensation for serving as an employee of Percheron Therapeutics . Mr. Padhye has received intellectual property interests from a discovery or technology relating to health care.